Synergic Interaction of Rifaximin and Mutaflor (Escherichia coliNissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats

The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis

(2018) Daniel C. Baumgart   Deutsches Arzteblatt International

Obestatin Accelerates the Healing of Acetic Acid-Induced Colitis in Rats

(2016) Aleksandra Matuszyk et al.   Oxidative Medicine and Cellular Longevity

Lamina propria macrophage phenotypes in relation to Escherichia coli in Crohn’s disease

(2015) Timothy R. Elliott et al.   BMC GASTROENTEROLOGY

Monocyte-derived Macrophages from Crohn's Disease Patients Are Impaired in the Ability to Control Intracellular Adherent-Invasive Escherichia coli and Exhibit Disordered Cytokine Secretion Profile

(2015) E. Vazeille et al.   Journal of Crohns & Colitis

Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis

(2015) Andreas Munk Petersen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Is Rifaximin Effective in Maintaining Remission in Crohn's Disease?

(2014) Anca Olivia Jigaranu et al.   DIGESTIVE DISEASES

Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis

(2014) Sumei Sha et al.   INFLAMMATION RESEARCH

Intestinal trefoil factor activates the PI3K/Akt signaling pathway to protect gastric mucosal epithelium from damage

(2014) ZHAORUI SUN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

A Review on Chemical-Induced Inflammatory Bowel Disease Models in Rodents

(2014) Puneet Kaur Randhawa et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study

(2014) Tomasz Gosiewski et al.   Gut Pathogens

Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis

(2013) Magdalena Pilarczyk-Zurek et al.   BMC GASTROENTEROLOGY

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

(2013) Dabo Xu et al.   GASTROENTEROLOGY

Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps

(2012) V. Kothary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development of Quantitative PCR Assays Targeting the 16S rRNA Genes of Enterococcus spp. and Their Application to the Identification of Enterococcus Species in Environmental Samples

(2012) Hodon Ryu et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

(2011) Cosimo Prantera et al.   GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin in the treatment of inflammatory bowel disease

(2011) Mario Guslandi   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

(2010) Harald Matthes et al.   BMC Complementary and Alternative Medicine

Saccharomyces Boulardii Plus Rifaximin in Mesalamine-intolerant Ulcerative Colitis

(2010) Mario Guslandi   JOURNAL OF CLINICAL GASTROENTEROLOGY

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

Intestinal bacteria and inflammatory bowel disease

(2009) Sandra Macfarlane et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Probiotic Escherichia coli Nissle 1917 (EcN) for Successful Remission Maintenance of Ulcerative Colitis in Children and Adolescents: an Open-Label Pilot Study 

(2008) J Henker et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE